scholarly journals Comparing Diagnostic Criteria for the Diagnosis of Neurocognitive Disorders in Multiple Sclerosis

Author(s):  
Laura M. Hancock ◽  
Bruce Hermann ◽  
Menno M. Schoonheim ◽  
Scott J. Hetzel ◽  
Bruno Brochet ◽  
...  
SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A205-A205
Author(s):  
Davide Sparasci ◽  
Raffaele Ferri ◽  
Anna Castelnovo ◽  
Claudio Gobbi ◽  
Chiara Zecca ◽  
...  

Abstract Introduction The aim of this study was to assess the prevalence of restless legs syndrome (RLS), periodic limb movements during sleep (PLMS) and their overlap in a large population of patients with multiple sclerosis (MS), and to compare clinical and paraclinical findings between patients with and without RLS/PLMS. Methods In this cross–sectional, observational, instrumental study, eighty-six patients (M/F: 27/59; mean age 48.0 ± 10.8 years) with a diagnosis of MS underwent a structured telephone interview assessing the five standard diagnostic criteria for RLS. Seventy-six participants underwent Video-polysomnography and Maintenance of Wakefulness Test (MWT). Instrumental and clinical findings were subsequently statistically compared to investigate their association with RLS and PLMS index (PLMSI). Results RLS and PLMS (PLMSI ≥15/h) prevalence in patients with MS was of 31.4% and 31.6% respectively. Among patients with RLS, 37.5% had a PLMSI ≥15/h. In the group with PLMS, 37.5% met all diagnostic criteria for RLS. No differences were found between patients with and without RLS (F = 0.99, p = 0.45), and between patients with and without a PLMSI ≥15/hour (F = 0.32 p = 0.94) on the pool of clinical and instrumental variables. Conclusion RLS is highly prevalent and severe in patients with MS. The prevalence of PLMS is comparable to the general population. The low percentage of patients with RLS having a high PLMSI, together with the absence of correlation between RLS and female gender and older age, support the existence of a distinct symptomatic form of RLS in MS. Support (if any):


2011 ◽  
Vol 69 (2) ◽  
pp. 292-302 ◽  
Author(s):  
Chris H. Polman ◽  
Stephen C. Reingold ◽  
Brenda Banwell ◽  
Michel Clanet ◽  
Jeffrey A. Cohen ◽  
...  

2021 ◽  
pp. 19-38
Author(s):  
Moyra Mortby ◽  
Bria Mele ◽  
Zahinoor Ismail ◽  
David Miller

Apathy, whether considered a syndrome or a symptom, is increasingly being diagnosed. Marin and colleagues first described apathy as a syndrome characterized by deficits in goal-directed behaviour, goal-directed cognitive activity, and emotions. Diagnostic criteria for apathy have since been published and are used in clinical and research settings to assess apathy in neurodegenerative and neuropsychiatric disorders. Apathy is assessed using a variety of methods, including diagnostic criteria-based clinical interviews, administration of assessment scales, and observational ratings of behaviours by a trained specialist. A number of assessment tools are available to assess severity and change of apathy symptoms and to distinguish apathy from other comorbid syndromes commonly observed in neurocognitive disorders. This chapter provides a detailed overview of apathy measures in neurocognitive disorders, focusing on diagnostic criteria and commonly used assessment tools.


Sign in / Sign up

Export Citation Format

Share Document